Don't Just Read the News, Understand It.
Published loading...Updated

ZYLOX Unicorn™ Vascular Closure Device Receives Regulatory Approval in Indonesia

  • Zylox-Tonbridge announced on May 26, 2025, in Hangzhou, China, that its ZYLOX Unicorn Vascular Closure Device received regulatory approval in Indonesia.
  • Following its regulatory clearance in China in mid-2024, Zylox-Tonbridge has now achieved its inaugural market approval in Southeast Asia with the product's authorization in Indonesia.
  • The ZYLOX Unicorn VCD is the first vascular closure device created within China, featuring a closure capability spanning 5F to 22F and designed to accommodate large-bore access sites.
  • Premarket clinical trials demonstrated the device’s strong safety, effective vascular closure, reduced puncture-site complications, and shortened patient immobilization time.
  • The approval will enhance the availability of advanced vascular intervention technologies in Indonesia and contribute to Zylox-Tonbridge’s ongoing growth throughout the Southeast Asian region.
Insights by Ground AI
Does this summary seem wrong?

77 Articles

All
Left
10
Center
29
Right
4
journalgazette.netjournalgazette.net
+74 Reposted by 74 other sources
Center

ZYLOX Unicorn™ Vascular Closure Device Receives Regulatory Approval in Indonesia

HANGZHOU, China, May 26, 2025 /PRNewswire/ -- Zylox-Tonbridge Medical Technology Co., Ltd. ("Zylox-Tonbridge" or the "Company") today announced that its proprietary ZYLOX Unicorn™ Vascular Closure Device (VCD) has received regulatory approval in Indonesia. This marks the ZYLOX Unicorn™ Vascular Closure…

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 67% of the sources are Center
67% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Charleston Gazette-Mail broke the news in Charleston, United States on Tuesday, May 27, 2025.
Sources are mostly out of (0)

Similar News Topics